New Horizontal Merger Guidelines Indicate Greater Scrutiny of High Tech and Pharmaceutical Transactions

Janet McDavid and Eric Stock

Antitrust Chronicle, 2010, vol. 10

Abstract: It also indicates greater Agency scrutiny of such transactions in industries characterized by differentiated products and high levels of R&D spendingâ€â€such as the high tech and pharmaceutical industries. Janet McDavid & Eric Stock (Hogan Lovells)

JEL-codes: G34 G38 (search for similar items in EconPapers)
Date: 2010
References: Add references at CitEc
Citations Track citations by RSS feed

Downloads: (external link)
http://www.competitionpolicyinternational.com/new- ... eutical-transactions (application/pdf)
Requires login and subscription

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: http://EconPapers.repec.org/RePEc:cpi:atchrn:10.2.2010:i=5719

Access Statistics for this article

More articles in Antitrust Chronicle from Competition Policy International
Series data maintained by Lindsay McSweeney ().